Global Center for Medical Innovation and T3 Labs
This week we hosted experts from the Global Center for Medical Innovation (GCMI) and T3 Labs. These two non-profit organizations are dedicated to providing an ecosystem and an environment that start-up healthcare technology companies can use to develop prototypes for new devices, as well as early stage production for them as they build toward commercialization.
Executive Director for GCMI, Tif Wilson, and Executive Director for T3 Labs, Andrew Stevenson, came by to talk about how their organizations are working to expand and improve the ecosystem for emerging healthcare technology cmopanies.
The Global Center for Medical Innovation (GCMI) is the Southeast’s first and only comprehensive medical device innovation center, dedicated to accelerating development, building businesses and improving health. GCMI opened its doors in April 2012 and to date has worked with over 40 different startups, clinician innovators, university tech transfer offices and academic researchers to design, engineer, prototype, and facilitate commercialization of a broad range of innovative medical devices.
GCMI’s core team of designers and engineers collaborate closely with startups, clinicians, researchers, new product development teams and medtech entrepreneurs to accelerate time to market while reducing costs. The independent, 501(c)(3) non-profit organization has a robust and ever-growing network of experts, including intellectual property, regulatory, quality systems and investors, to help bring ideas from concept to market. In addition, through a close collaboration with our development partner, T3 Labs, medical device entrepreneurs and new product development teams have all of the critical resources they need to efficiently bring new products from an idea through GLP preclinical studies, all in Midtown Atlanta.
With 15 years of experience, T3’s mission remains – to provide high-value pre-clinical GLP (Good Lab Practices) compliant testing and training services to medical device, biologics, and pharmaceutical developers and manufacturers. We work with industry and academic sponsors to improve patient care by more effectively and efficiently developing and commercializing their devices and products. Contact them at (404) 251-0600.
T3 Labs is an independently-operated, privately-held, AAALAC accredited, GLP-compliant non-profit 501(c)(3) organization. In 2012, T3 became a wholly-owned subsidiary of a joint-operating company formed by Saint Joseph’s Health System and Emory Healthcare. Emory is recognized internationally as a leading academic medical center. By serving our industry and academic collaborators, T3 Labs is committed to supporting Emory/Saint Joseph’s tripartite mission: enabling discovery and innovation – via Testing; facilitating healthcare provider education – via Training; and enhancing patient-care – via medical product Translation.
Tif Wilson, Executive Director of Global Center for Medical Innovation
- MBA, Management & Strategy, Georgetown University, McDonough School of Business
- Previous VP, Business Development & Strategy, ACell, Inc
- 2012 HBA Women in Healthcare Leadership Award Nominee
Andrew Stevenson, Executive Director of T3 Labs
- MBA, International Business, University of Delaware, Lerner College of Business and Economics
- Previous Research Scientist, University of Pennsylvania, Departments of Pharmacology & Radiology
- Former Senior Scientist, Bristol-Meyers, Squibb
- Previous Project Leader/Director, Abbott